BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8302605)

  • 1. CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.
    Bates S; Bonetta L; MacAllan D; Parry D; Holder A; Dickson C; Peters G
    Oncogene; 1994 Jan; 9(1):71-9. PubMed ID: 8302605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein.
    Bates S; Parry D; Bonetta L; Vousden K; Dickson C; Peters G
    Oncogene; 1994 Jun; 9(6):1633-40. PubMed ID: 8183557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
    Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
    Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
    Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
    Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein.
    Hall FL; Williams RT; Wu L; Wu F; Carbonaro-Hall DA; Harper JW; Warburton D
    Oncogene; 1993 May; 8(5):1377-84. PubMed ID: 8479754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclins and cdks throughout murine carcinogenesis.
    Yerly-Motta V; Contassot E; Pavy JJ; Tiberghien P; Hervé P
    Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1217-28. PubMed ID: 10643971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein.
    Bartkova J; Lukas J; Strauss M; Bartek J
    J Pathol; 1994 Mar; 172(3):237-45. PubMed ID: 8195927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma cell cycle: study of Long-Evans cinnamon rats.
    Masaki T; Shiratori Y; Rengifo W; Igarashi K; Matsumoto K; Nishioka M; Hatanaka Y; Omata M
    Hepatology; 2000 Oct; 32(4 Pt 1):711-20. PubMed ID: 11003614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA.
    Xiong Y; Zhang H; Beach D
    Cell; 1992 Oct; 71(3):505-14. PubMed ID: 1358458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.
    Matsushime H; Ewen ME; Strom DK; Kato JY; Hanks SK; Roussel MF; Sherr CJ
    Cell; 1992 Oct; 71(2):323-34. PubMed ID: 1423597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The D-type cyclins and their role in tumorigenesis.
    Peters G
    J Cell Sci Suppl; 1994; 18():89-96. PubMed ID: 7883799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer.
    Schauer IE; Siriwardana S; Langan TA; Sclafani RA
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7827-31. PubMed ID: 8052667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 protein expression in lung cancer.
    Yang WI; Chung KY; Shin DH; Kim YB
    Yonsei Med J; 1996 Apr; 37(2):142-50. PubMed ID: 8711937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts.
    Lucibello FC; Sewing A; Brüsselbach S; Bürger C; Müller R
    J Cell Sci; 1993 May; 105 ( Pt 1)():123-33. PubMed ID: 8360268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early overexpression of cyclin D1 protein in mouse skin carcinogenesis.
    Robles AI; Conti CJ
    Carcinogenesis; 1995 Apr; 16(4):781-6. PubMed ID: 7728955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP.
    Sewing A; Bürger C; Brüsselbach S; Schalk C; Lucibello FC; Müller R
    J Cell Sci; 1993 Feb; 104 ( Pt 2)():545-55. PubMed ID: 8389378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel cyclin-like protein in human tumor cells.
    Williams RT; Wu L; Carbonaro-Hall DA; Tolo VT; Hall FL
    J Biol Chem; 1993 Apr; 268(12):8871-80. PubMed ID: 8386171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of cyclin D and cyclin A in human vascular endothelial cells of the skin.
    Inohara S
    Acta Derm Venereol; 1994 Nov; 74(6):471-2. PubMed ID: 7701885
    [No Abstract]   [Full Text] [Related]  

  • 19. A cyclin D1 intrinsically disordered domain accesses modified histone motifs to govern gene transcription.
    Jiao X; Di Sante G; Casimiro MC; Tantos A; Ashton AW; Li Z; Quach Y; Bhargava D; Di Rocco A; Pupo C; Crosariol M; Lazar T; Tompa P; Wang C; Yu Z; Zhang Z; Aldaaysi K; Vadlamudi R; Mann M; Skordalakes E; Kossenkov A; Du Y; Pestell RG
    Oncogenesis; 2024 Jan; 13(1):4. PubMed ID: 38191593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic identification of a direct role for cyclin d1 in DNA damage repair.
    Jirawatnotai S; Hu Y; Livingston DM; Sicinski P
    Cancer Res; 2012 Sep; 72(17):4289-93. PubMed ID: 22915759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.